Strengthened leadership team with key appointments, including Barry Quart, Pharm.D. as CEO, and David Szekeres as President, bringing deep ...

To tackle the inequity in medication access, a societal issue especially in developing nations, a team of undergraduate student-researchers at the University of Ottawa has developed a new ...

2025 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill " or the "Company"), a specialty biopharmaceutical company, today announced its plan to submit a UK Marketing Authorisation ...

RedHill plans to submit UK MAA 1 for Talicia for H. pylori infection, using MHRA's 2 new fast-track approval process, referencing FDA approval, with potential UK approval in Q4/25 Listed by ...

RedHill Biopharma (RDHL) announced its plan to submit a UK Marketing Authorisation Application for Talicia for treatment of helicobacter pylori infection under the Medicines and Healthcare ...

RedHill plans to submit UK MAA 1 for Talicia for H. pylori infection, using MHRA's 2 new fast-track approval process, referencing FDA approval, with potential UK approval in Q4/25 Listed by ACG 3 ...

GC Biopharma announced on the 14th that it received approval from the Ministry of Food and Drug Safety for the clinical trial plan (IND) for an adult combined vaccine against tetanus, diphtheria ...

GVB Biopharma, developer, manufacturer and global distributor of hemp-derived cannabinoid products, has launched CBT Isolate. CBT, also known as cannabicitran, is a rare cannabinoid that demonstrates ...